Shandong Weigao Group Medical Polymer Company Limited (FRA:UK2)

Market Cap	2.81B
Revenue (ttm)	1.56B
Net Income (ttm)	233.85M
Shares Out	n/a
EPS (ttm)	0.05
PE Ratio	12.02
Forward PE	10.35
Dividend	0.03 (4.43%)
Ex-Dividend Date	Oct 21, 2025

Volume	n/a
Average Volume	256
Open	0.6050
Previous Close	0.6450
Day's Range	0.6050 - 0.6050
52-Week Range	0.4960 - 0.7650
Beta	n/a
RSI	45.15
Earnings Date	Nov 11, 2025

About FRA:UK2

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1988
• Employees: 12,719
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UK2

Financial Performance

In 2024, FRA:UK2's revenue was 13.09 billion, a decrease of -1.08% compared to the previous year's 13.23 billion. Earnings were 2.07 billion, an increase of 3.24%.

Financial numbers in CNY